Ivabradine Hydrochloride Tablet — FDA Drug Shortage

To Be Discontinued — Amgen Inc.

The FDA lists a drug shortage record for Ivabradine Hydrochloride Tablet (tablet) from Amgen Inc. with status To Be Discontinued. The shortage was first posted on Mar 24, 2026.

Shortage details

Status
To Be Discontinued
Company
Amgen Inc.
Package NDC
55513-810-60
Dosage Form
Tablet
Presentation
Corlanor, Tablet, eq. 7.5 mg base (NDC 55513-810-60)
Initial Posting
Mar 24, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.